ArticleTherapeutic advances in medical oncology2020

Low intratumor heterogeneity correlates with increased response to PD-1 blockade in renal cell carcinoma.

Xia Ran et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.